FindTrial
Sign In

Analgesia with epidural dexmedetomidine in the phase of labor andthe risk of cesarean delivery

Analgesia with epidural dexmedetomidine in the phase of labor andthe risk of cesarean delivery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15006643
Enrollment
Unknown
Registered
2015-06-23
Start date
2015-06-22
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nulliparous women in spontaneous labor or with spontaneous rupture of the membranes.

Interventions

Dexmedetomidine group:epidural dexmedetomidine
Levobupivacaine group:epidural levobupivacaine and sufentanil

Sponsors

Department of Anesthesiology, Guangzhou Women andChildren Medical Center
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: all healthy nulliparous women with term aged between 18y and45y; singleton pregnancies who presented in spontaneous labor or with spontaneous rupture of the membranes.

Exclusion criteria

Exclusion criteria: a nonvertex presentation; scheduled induction of labor; fetus with known or suspected congenital abnormalites;any contraindication to dexmedetomidine or opioids analgesia

Design outcomes

Primary

MeasureTime frame
the method of delivery;—

Secondary

MeasureTime frame
the indication for cesarean delivery;the quality of analgesia;the duration of labor;the method of vaginal delivery;neonatal outcome;the incidence of abnormal fetal heart rate;—

Countries

China

Contacts

Public ContactSong Xing-Rong
songxr1966@yeah.net+86 13922416403

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026